Wedmont Private Capital Has $2.44 Million Stake in Lam Research Corporation $LRCX

Key Points

• Wedmont Private Capital has increased its stake in Lam Research Corporation by 40.8%, now owning a total of 24,439 shares valued at approximately $2.44 million.
• Lam Research recently reported a strong quarterly earnings result with an EPS of $1.33, exceeding analysts' expectations, while also announcing an increase in its quarterly dividend from $0.23 to $0.26 per share.
• Analysts have raised their price targets for Lam Research, with the consensus rating being a "Moderate Buy," and an average price target of $107.96.

Wedmont Private Capital lifted its stake in shares of Lam Research Corporation (NASDAQ:LRCX - Free Report) by 40.8% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 24,439 shares of the semiconductor company's stock after acquiring an additional 7,077 shares during the quarter. Wedmont Private Capital's holdings in Lam Research were worth $2,439,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Vanguard Group Inc. boosted its stake in shares of Lam Research by 6.9% during the 1st quarter. Vanguard Group Inc. now owns 129,152,102 shares of the semiconductor company's stock valued at $9,389,358,000 after buying an additional 8,364,375 shares during the period. Nuveen LLC acquired a new stake in shares of Lam Research during the 1st quarter valued at $604,344,000. Price T Rowe Associates Inc. MD boosted its stake in shares of Lam Research by 99.7% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 5,739,221 shares of the semiconductor company's stock valued at $417,242,000 after buying an additional 2,864,863 shares during the period. Boston Partners boosted its stake in shares of Lam Research by 9,978.3% during the 1st quarter. Boston Partners now owns 2,350,362 shares of the semiconductor company's stock valued at $170,787,000 after buying an additional 2,327,041 shares during the period. Finally, Mackenzie Financial Corp boosted its stake in shares of Lam Research by 932.6% during the 4th quarter. Mackenzie Financial Corp now owns 2,347,536 shares of the semiconductor company's stock valued at $169,563,000 after buying an additional 2,120,197 shares during the period. Institutional investors and hedge funds own 84.61% of the company's stock.

Lam Research Price Performance

Shares of LRCX stock traded up $0.60 during trading hours on Friday, reaching $126.92. 24,270,137 shares of the company were exchanged, compared to its average volume of 9,983,844. Lam Research Corporation has a fifty-two week low of $56.32 and a fifty-two week high of $128.70. The stock's fifty day moving average is $103.36 and its two-hundred day moving average is $88.26. The company has a market cap of $160.05 billion, a price-to-earnings ratio of 30.51, a P/E/G ratio of 1.62 and a beta of 1.76. The company has a debt-to-equity ratio of 0.38, a current ratio of 2.21 and a quick ratio of 1.55.

Lam Research (NASDAQ:LRCX - Get Free Report) last announced its earnings results on Wednesday, July 30th. The semiconductor company reported $1.33 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.21 by $0.12. The company had revenue of $5.17 billion for the quarter, compared to analyst estimates of $4.99 billion. Lam Research had a net margin of 29.07% and a return on equity of 58.17%. Lam Research's quarterly revenue was up 33.6% on a year-over-year basis. During the same period in the prior year, the business earned $1.03 earnings per share. Lam Research has set its Q1 2026 guidance at 1.100-1.300 EPS. Sell-side analysts forecast that Lam Research Corporation will post 3.71 earnings per share for the current fiscal year.

Lam Research Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Shareholders of record on Wednesday, September 24th will be paid a $0.26 dividend. The ex-dividend date of this dividend is Wednesday, September 24th. This is a boost from Lam Research's previous quarterly dividend of $0.23. This represents a $1.04 annualized dividend and a yield of 0.8%. Lam Research's payout ratio is currently 22.12%.

Analysts Set New Price Targets

LRCX has been the subject of several analyst reports. TD Cowen lifted their price objective on shares of Lam Research from $100.00 to $125.00 and gave the company a "buy" rating in a research note on Thursday, July 31st. Mizuho lifted their price objective on shares of Lam Research from $120.00 to $130.00 and gave the company an "outperform" rating in a research note on Friday, September 12th. The Goldman Sachs Group initiated coverage on shares of Lam Research in a research note on Thursday, July 10th. They issued a "buy" rating and a $115.00 price objective for the company. Oppenheimer lifted their price objective on shares of Lam Research from $110.00 to $120.00 and gave the company an "outperform" rating in a research note on Thursday, July 31st. Finally, KeyCorp lifted their price objective on shares of Lam Research from $105.00 to $115.00 and gave the company an "overweight" rating in a research note on Tuesday, July 15th. Twenty equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $107.96.

Lam Research Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.